Comment to: Baloxavir efficacy in North American Adults

Eur J Intern Med. 2020 Feb:72:99-101. doi: 10.1016/j.ejim.2019.11.005. Epub 2020 Jan 15.

Authors

Simon Portsmouth¹, Keiko Kawaguchi², Takeki Uehara², Frederick G Hayden³

Affiliations

¹ Shionogi Inc., Florham Park, 300 Campus Drive, Florham Park, NJ, USA. Electronic address: simon.portsmouth@shionogi.com.
² Shionogi & Co., Ltd., Osaka, Japan.
³ Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, VA, USA.

PMID: 31954593
DOI: 10.1016/j.ejim.2019.11.005

No abstract available

Keywords: Baloxavir; Clinical trial; Influenza; Time to alleviation of symptoms (TTAS).

Publication types

Letter
Comment

MeSH terms

Adult
Dibenzothiepins
Humans
Influenza, Human*
Morpholines
Oxazines
Pyridines
Pyridones
Thiepins*
Triazines
United States

Substances

Dibenzothiepins
Morpholines
Oxazines
Pyridines
Pyridones
Thiepins
Triazines
baloxavir